Global Harvest Pharma is a leading generic pharmaceutical company specializing in developing and marketing injectable hospital products.
King of Prussia, PA
Hong Kong, China
GHP was founded in 2001 as a provider of strategic partnering to the pharmaceutical and biotechnology industries in:
In 2014 , GHP transitioned to developing and marketing its own injectable hospital products.
Dr. Wong has more than 30 years of experience in the healthcare industry, with a primary focus on business development, new product & market development, strategic alliances, and operations & administration.
Dr. Wong’s career began in 1972 as a pharmaceutical industry researcher at the National Bureau of Economics Research and at Wainwright Securities, both in New York, while simultaneously lecturing at CUNY, Columbia University and St. John’s University.
He later held various management positions with Warner Lambert and Parke Davis, directing pricing and prime vendor operations, corporate strategic planning, business development, licensing, and product & market opportunity assessment & valuation. During the mid 1990’s, Dr. Wong co-founded several successful consulting, training and communication start-ups , leveraging web-based learning, product marketing portals and knowledge management systems for the pharmaceutical industry.
Dr. Wong also co-founded an international consulting practice focusing on business development, M&A, and technology transfer between Asian manufacturing companies and global pharmaceutical and biotech companies.
Rick Ricciardi has 30 plus years of experience in the pharmaceutical industry. Throughout his career he has held positions of increasing responsibility in business development, strategic planning, major investments planning, manufacturing management, and engineering. In addition to his association with Global Harvest Pharma, Rick is president of Romar Associates, guiding clients in the planning and implementation of acquisitions and divestitures.
Prior to positions in the above companies, Rick spent 21 years with Hoffmann-La Roche Inc., most recently as Vice President, Corporate Strategic Planning and Business Development and Vice President, Engineering and Construction. In the latter position, he directed the acquisition, design, and construction in South Carolina of a greenfield site. This $500 million dollar, multi-purpose development center was established to develop processes and to manufacture active pharmaceutical ingredients. Before joining Roche, Mr. Ricciardi held positions in process development, engineering and manufacturing at Warner Lambert and Dow Chemical. He holds a BS in Chemical Engineering from the New Jersey Institute of Technology and an MBA from Fairleigh Dickinson University in New Jersey.
GHP values partnerships in hospital injectable products marketed world-wide including:
GHP offers challenging and rewarding career opportunities for team members who are passionate about achieving personal and professional goals in an environment that encourages independent thinking and collaborative team actions.